1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Respiratory Drug Consumption 2015-2025

2.1.2 Respiratory Drug Consumption CAGR by Region

2.2 Respiratory Drug Segment by Type

2.2.1 Inhalable & Nasal Spray

2.2.2 Oral

2.2.3 Others

2.3 Respiratory Drug Consumption by Type

2.3.1 Global Respiratory Drug Consumption Market Share by Type (2015-2020)

2.3.2 Global Respiratory Drug Revenue and Market Share by Type (2015-2020)

2.3.3 Global Respiratory Drug Sale Price by Type (2015-2020)

2.4 Respiratory Drug Segment by Application

2.4.1 Hospital

2.4.2 Drugs Store

2.5 Respiratory Drug Consumption by Application

2.5.1 Global Respiratory Drug Consumption Market Share by Type (2015-2020)

2.5.2 Global Respiratory Drug Value and Market Share by Type (2015-2020)

2.5.3 Global Respiratory Drug Sale Price by Type (2015-2020)

3 Global Respiratory Drug by Company

3.1 Global Respiratory Drug Sales Market Share by Company

3.1.1 Global Respiratory Drug Sales by Company (2018-2020)

3.1.2 Global Respiratory Drug Sales Market Share by Company (2018-2020)

3.2 Global Respiratory Drug Revenue Market Share by Company

3.2.1 Global Respiratory Drug Revenue by Company (2018-2020)

3.2.2 Global Respiratory Drug Revenue Market Share by Company (2018-2020)

3.3 Global Respiratory Drug Sale Price by Company

3.4 Global Respiratory Drug Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Respiratory Drug Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Respiratory Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Respiratory Drug by Regions

4.1 Respiratory Drug by Regions

4.2 Americas Respiratory Drug Consumption Growth

4.3 APAC Respiratory Drug Consumption Growth

4.4 Europe Respiratory Drug Consumption Growth

4.5 Middle East & Africa Respiratory Drug Consumption Growth

5 Americas

5.1 Americas Respiratory Drug Consumption by Countries

5.1.1 Americas Respiratory Drug Consumption by Countries (2015-2020)

5.1.2 Americas Respiratory Drug Value by Countries (2015-2020)

5.2 Americas Respiratory Drug Consumption by Type

5.3 Americas Respiratory Drug Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Respiratory Drug Consumption by Regions

6.1.1 APAC Respiratory Drug Consumption by Regions (2015-2020)

6.1.2 APAC Respiratory Drug Value by Regions (2015-2020)

6.2 APAC Respiratory Drug Consumption by Type

6.3 APAC Respiratory Drug Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Respiratory Drug by Countries

7.1.1 Europe Respiratory Drug Consumption by Countries (2015-2020)

7.1.2 Europe Respiratory Drug Value by Countries (2015-2020)

7.2 Europe Respiratory Drug Consumption by Type

7.3 Europe Respiratory Drug Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Respiratory Drug by Countries

8.1.1 Middle East & Africa Respiratory Drug Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Respiratory Drug Value by Countries (2015-2020)

8.2 Middle East & Africa Respiratory Drug Consumption by Type

8.3 Middle East & Africa Respiratory Drug Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Respiratory Drug Distributors

10.3 Respiratory Drug Customer

11 Global Respiratory Drug Market Forecast

11.1 Global Respiratory Drug Consumption Forecast (2021-2025)

11.2 Global Respiratory Drug Forecast by Regions

11.2.1 Global Respiratory Drug Forecast by Regions (2021-2025)

11.2.2 Global Respiratory Drug Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast byRegions

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Respiratory Drug Forecast by Type

11.8 Global Respiratory Drug Forecast by Application

12 Key Players Analysis

12.1 GSK

12.1.1 Company Information

12.1.2 Respiratory Drug Product Offered

12.1.3 GSK Respiratory Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 GSK Latest Developments

12.2 Sumitomo Dainippon

12.2.1 Company Information

12.2.2 Respiratory Drug Product Offered

12.2.3 Sumitomo Dainippon Respiratory Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 Sumitomo Dainippon Latest Developments

12.3 AstraZeneca

12.3.1 Company Information

12.3.2 Respiratory Drug Product Offered

12.3.3 AstraZeneca Respiratory Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 AstraZeneca Latest Developments

12.4 Vertex

12.4.1 Company Information

12.4.2 Respiratory Drug Product Offered

12.4.3 Vertex Respiratory Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Vertex Latest Developments

12.5 Roche

12.5.1 Company Information

12.5.2 Respiratory Drug Product Offered

12.5.3 Roche Respiratory Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 Roche Latest Developments

12.6 Boehringer Ingelheim

12.6.1 Company Information

12.6.2 Respiratory Drug Product Offered

12.6.3 Boehringer Ingelheim Respiratory Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 Boehringer Ingelheim Latest Developments

12.7 Chiesi

12.7.1 Company Information

12.7.2 Respiratory Drug Product Offered

12.7.3 Chiesi Respiratory Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 Chiesi Latest Developments

12.8 Novartis

12.8.1 Company Information

12.8.2 Respiratory Drug Product Offered

12.8.3 Novartis Respiratory Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 Novartis Latest Developments

12.9 Mylan

12.9.1 Company Information

12.9.2 Respiratory Drug Product Offered

12.9.3 Mylan Respiratory Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 Mylan Latest Developments

12.10 Teva

12.10.1 Company Information

12.10.2 Respiratory Drug Product Offered

12.10.3 Teva Respiratory Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.10.4 Main Business Overview

12.10.5 Teva Latest Developments

12.11 Merck

12.11.1 Company Information

12.11.2 Respiratory Drug Product Offered

12.11.3 Merck Respiratory Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.11.4 Main Business Overview

12.11.5 Merck Latest Developments

12.12 Beximco

12.12.1 Company Information

12.12.2 Respiratory Drug Product Offered

12.12.3 Beximco Respiratory Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.12.4 Main Business Overview

12.12.5 Beximco Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Respiratory Drug Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of Inhalable & Nasal Spray

Table 5. Major Players of Oral

Table 6. Major Players of Others

Table 7. Global Consumption Sales by Type (2015-2020)

Table 8. Global Respiratory Drug Consumption Market Share by Type (2015-2020)

Table 9. Global Respiratory Drug Revenue by Type (2015-2020) ($ million)

Table 10. Global Respiratory Drug Value Market Share by Type (2015-2020) ($ Millions)

Table 11. Global Respiratory Drug Sale Price by Type (2015-2020)

Table 12. Global Consumption Sales by Application (2015-2020)

Table 13. Global Respiratory Drug Consumption Market Share by Application (2015-2020)

Table 14. Global Respiratory Drug Value by Application (2015-2020)

Table 15. Global Respiratory Drug Value Market Share by Application (2015-2020)

Table 16. Global Respiratory Drug Sale Price by Application (2015-2020)

Table 17. Global Respiratory Drug Sales by Company (2017-2019) (M Units)

Table 18. Global Respiratory Drug Sales Market Share by Company (2017-2019)

Table 19. Global Respiratory Drug Revenue by Company (2017-2019) ($ Millions)

Table 20. Global Respiratory Drug Revenue Market Share by Company (2017-2019)

Table 21. Global Respiratory Drug Sale Price by Company (2017-2019)

Table 22. Global Respiratory Drug Manufacturing Base Distribution and Sales Area by Manufacturers

Table 23. Players Respiratory Drug Products Offered

Table 24. Respiratory Drug Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 25. Global Respiratory Drug Consumption by Regions 2015-2020 (M Units)

Table 26. Global Respiratory Drug Consumption Market Share by Regions 2015-2020

Table 27. Global Respiratory Drug Value by Regions 2015-2020 ($ Millions)

Table 28. Global Respiratory Drug Value Market Share by Regions 2015-2020

Table 29. Americas Respiratory Drug Consumption by Countries (2015-2020) (M Units)

Table 30. Americas Respiratory Drug Consumption Market Share by Countries (2015-2020)

Table 31. Americas Respiratory Drug Value by Countries (2015-2020) ($ Millions)

Table 32. Americas Respiratory Drug Value Market Share by Countries (2015-2020)

Table 33. Americas Respiratory Drug Consumption by Type (2015-2020) (M Units)

Table 34. Americas Respiratory Drug Consumption Market Share by Type (2015-2020)

Table 35. Americas Respiratory Drug Consumption by Application (2015-2020) (M Units)

Table 36. Americas Respiratory Drug Consumption Market Share by Application (2015-2020)

Table 37. APAC Respiratory Drug Consumption by Regions (2015-2020) (M Units)

Table 38. APAC Respiratory Drug Consumption Market Share by Regions (2015-2020)

Table 39. APAC Respiratory Drug Value by Regions (2015-2020) ($ Millions)

Table 40. APAC Respiratory Drug Value Market Share by Regions (2015-2020)

Table 41. APAC Respiratory Drug Consumption by Type (2015-2020) (M Units)

Table 42. APAC Respiratory Drug Consumption Market Share by Type (2015-2020)

Table 43. APAC Respiratory Drug Consumption by Application (2015-2020) (M Units)

Table 44. APAC Respiratory Drug Consumption Market Share by Application (2015-2020)

Table 45. Europe Respiratory Drug Consumption by Countries (2015-2020) (M Units)

Table 46. Europe Respiratory Drug Consumption Market Share by Countries (2015-2020)

Table 47. Europe Respiratory Drug Value by Countries (2015-2020) ($ Millions)

Table 48. Europe Respiratory Drug Value Market Share by Countries (2015-2020)

Table 49. Europe Respiratory Drug Consumption by Type (2015-2020) (M Units)

Table 50. Europe Respiratory Drug Consumption Market Share by Type (2015-2020)

Table 51. Europe Respiratory Drug Consumption by Application (2015-2020) (M Units)

Table 52. Europe Respiratory Drug Consumption Market Share by Application (2015-2020)

Table 53. Middle East & Africa Respiratory Drug Consumption by Countries (2015-2020) (M Units)

Table 54. Middle East & Africa Respiratory Drug Consumption Market Share by Countries (2015-2020)

Table 55. Middle East & Africa Respiratory Drug Value by Countries (2015-2020) ($ Millions)

Table 56. Middle East & Africa Respiratory Drug Value Market Share by Countries (2015-2020)

Table 57. Middle East & Africa Respiratory Drug Consumption by Type (2015-2020) (M Units)

Table 58. Middle East & Africa Respiratory Drug Consumption Market Share by Type (2015-2020)

Table 59. Middle East & Africa Respiratory Drug Consumption by Application (2015-2020) (M Units)

Table 60. Middle East & Africa Respiratory Drug Consumption Market Share by Application (2015-2020)

Table 61. Respiratory Drug Distributors List

Table 62. Respiratory Drug Customer List

Table 63. Global Respiratory Drug Consumption Forecast by Countries (2021-2025) (M Units)

Table 64. Global Respiratory Drug Consumption Market Forecast by Regions

Table 65. Global Respiratory Drug Value Forecast by Countries (2021-2025) ($ Millions)

Table 66. Global Respiratory Drug Value Market Share Forecast by Regions

Table 67. Global Respiratory Drug Consumption Forecast by Type (2021-2025) (M Units)

Table 68. Global Respiratory Drug Consumption Market Share Forecast by Type (2021-2025)

Table 69. Global Respiratory Drug Value Forecast by Type (2021-2025) ($ Millions)

Table 70. Global Respiratory Drug Value Market Share Forecast by Type (2021-2025)

Table 71. Global Respiratory Drug Consumption Forecast by Application (2021-2025) (M Units)

Table 72. Global Respiratory Drug Consumption Market Share Forecast by Application (2021-2025)

Table 73. Global Respiratory Drug Value Forecast by Application (2021-2025) ($ Millions)

Table 74. Global Respiratory Drug Value Market Share Forecast by Application (2021-2025)

Table 75. GSK Product Offered

Table 76. GSK Respiratory Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 77. GSK Main Business

Table 78. GSK Latest Developments

Table 79. GSK Basic Information, Company Total Revenue (in $ million), Respiratory Drug Manufacturing Base, Sales Area and Its Competitors

Table 80. Sumitomo Dainippon Product Offered

Table 81. Sumitomo Dainippon Respiratory Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 82. Sumitomo Dainippon Main Business

Table 83. Sumitomo Dainippon Latest Developments

Table 84. Sumitomo Dainippon Basic Information, Company Total Revenue (in $ million), Respiratory Drug Manufacturing Base, Sales Area and Its Competitors

Table 85. AstraZeneca Product Offered

Table 86. AstraZeneca Respiratory Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 87. AstraZeneca Main Business

Table 88. AstraZeneca Latest Developments

Table 89. AstraZeneca Basic Information, Company Total Revenue (in $ million), Respiratory Drug Manufacturing Base, Sales Area and Its Competitors

Table 90. Vertex Product Offered

Table 91. Vertex Respiratory Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 92. Vertex Main Business

Table 93. Vertex Latest Developments

Table 94. Vertex Basic Information, Company Total Revenue (in $ million), Respiratory Drug Manufacturing Base, Sales Area and Its Competitors

Table 95. Roche Product Offered

Table 96. Roche Respiratory Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 97. Roche Main Business

Table 98. Roche Latest Developments

Table 99. Roche Basic Information, Company Total Revenue (in $ million), Respiratory Drug Manufacturing Base, Sales Area and Its Competitors

Table 100. Boehringer Ingelheim Product Offered

Table 101. Boehringer Ingelheim Respiratory Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 102. Boehringer Ingelheim Main Business

Table 103. Boehringer Ingelheim Latest Developments

Table 104. Boehringer Ingelheim Basic Information, Company Total Revenue (in $ million), Respiratory Drug Manufacturing Base, Sales Area and Its Competitors

Table 105. Chiesi Product Offered

Table 106. Chiesi Basic Information, Company Total Revenue (in $ million), Respiratory Drug Manufacturing Base, Sales Area and Its Competitors

Table 107. Chiesi Main Business

Table 108. Chiesi Latest Developments

Table 109. Chiesi Respiratory Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 110. Novartis Product Offered

Table 111. Novartis Respiratory Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 112. Novartis Main Business

Table 113. Novartis Latest Developments

Table 114. Novartis Basic Information, Company Total Revenue (in $ million), Respiratory Drug Manufacturing Base, Sales Area and Its Competitors

Table 115. Mylan Product Offered

Table 116. Mylan Respiratory Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 117. Mylan Main Business

Table 118. Mylan Latest Developments

Table 119. Mylan Basic Information, Company Total Revenue (in $ million), Respiratory Drug Manufacturing Base, Sales Area and Its Competitors

Table 120. Teva Product Offered

Table 121. Teva Respiratory Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 122. Teva Main Business

Table 123. Teva Latest Developments

Table 124. Teva Basic Information, Company Total Revenue (in $ million), Respiratory Drug Manufacturing Base, Sales Area and Its Competitors

Table 125. Merck Product Offered

Table 126. Merck Respiratory Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 127. Merck Main Business

Table 128. Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 129. Merck Latest Developments

Table 130. Beximco Product Offered

Table 131. Beximco Respiratory Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 132. Beximco Main Business

Table 133. Beximco Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 134. Beximco Latest Developments

List of Figures

Figure 1. Picture of Respiratory Drug

Figure 2. Respiratory Drug Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global Respiratory Drug Consumption Growth Rate 2015-2025 (M Units)

Figure 5. Global Respiratory Drug Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of Inhalable & Nasal Spray

Figure 7. Product Picture of Oral

Figure 8. Product Picture of Others

Figure 9. Global Respiratory Drug Consumption Market Share by Type (2015-2020)

Figure 10. Global Respiratory Drug Value Market Share by Type (2015-2020)

Figure 11. Respiratory Drug Consumed in Hospital

Figure 12. Global Respiratory Drug Market: Hospital (2015-2020) (M Units)

Figure 13. Global Respiratory Drug Market: Hospital (2015-2020) ($ Millions)

Figure 14. Respiratory Drug Consumed in Drugs Store

Figure 15. Global Respiratory Drug Market: Drugs Store (2015-2020) (M Units)

Figure 16. Global Respiratory Drug Market: Drugs Store (2015-2020) ($ Millions)

Figure 17. Global Respiratory Drug Consumption Market Share by Application (2015-2020)

Figure 18. Global Respiratory Drug Value Market Share by Application (2015-2020)

Figure 19. Global Respiratory Drug Sales Market Share by Company in 2017

Figure 20. Global Respiratory Drug Sales Market Share by Company in 2019

Figure 21. Global Respiratory Drug Revenue Market Share by Company in 2017

Figure 22. Global Respiratory Drug Revenue Market Share by Company in 2019

Figure 23. Global Respiratory Drug Sale Price by Company in 2019

Figure 24. Global Respiratory Drug Consumption Market Share by Regions 2015-2020

Figure 25. Global Respiratory Drug Value Market Share by Regions 2015-2020

Figure 26. Americas Respiratory Drug Consumption 2015-2020 (M Units)

Figure 27. Americas Respiratory Drug Value 2015-2020 ($ Millions)

Figure 28. APAC Respiratory Drug Consumption 2015-2020 (M Units)

Figure 29. APAC Respiratory Drug Value 2015-2020 ($ Millions)

Figure 30. Europe Respiratory Drug Consumption 2015-2020 (M Units)

Figure 31. Europe Respiratory Drug Value 2015-2020 ($ Millions)

Figure 32. Middle East & Africa Respiratory Drug Consumption 2015-2020 (M Units)

Figure 33. Middle East & Africa Respiratory Drug Value 2015-2020 ($ Millions)

Figure 34. Americas Respiratory Drug Consumption Market Share by Countries in 2019

Figure 35. Americas Respiratory Drug Value Market Share by Countries in 2019

Figure 36. Americas Respiratory Drug Consumption Market Share by Type in 2019

Figure 37. Americas Respiratory Drug Consumption Market Share by Application in 2019

Figure 38. United States Respiratory Drug Consumption Growth 2015-2020 (M Units)

Figure 39. United States Respiratory Drug Value Growth 2015-2020 ($ Millions)

Figure 40. Canada Respiratory Drug Consumption Growth 2015-2020 (M Units)

Figure 41. Canada Respiratory Drug Value Growth 2015-2020 ($ Millions)

Figure 42. Mexico Respiratory Drug Consumption Growth 2015-2020 (M Units)

Figure 43. Mexico Respiratory Drug Value Growth 2015-2020 ($ Millions)

Figure 44. APAC Respiratory Drug Consumption Market Share by Countries in 2019

Figure 45. APAC Respiratory Drug Value Market Share by Regions in 2019

Figure 46. APAC Respiratory Drug Consumption Market Share by Type in 2019

Figure 47. APAC Respiratory Drug Consumption Market Share by Application in 2019

Figure 48. China Respiratory Drug Consumption Growth 2015-2020 (M Units)

Figure 49. China Respiratory Drug Value Growth 2015-2020 ($ Millions)

Figure 50. Japan Respiratory Drug Consumption Growth 2015-2020 (M Units)

Figure 51. Japan Respiratory Drug Value Growth 2015-2020 ($ Millions)

Figure 52. Korea Respiratory Drug Consumption Growth 2015-2020 (M Units)

Figure 53. Korea Respiratory Drug Value Growth 2015-2020 ($ Millions)

Figure 54. Southeast Asia Respiratory Drug Consumption Growth 2015-2020 (M Units)

Figure 55. Southeast Asia Respiratory Drug Value Growth 2015-2020 ($ Millions)

Figure 56. India Respiratory Drug Consumption Growth 2015-2020 (M Units)

Figure 57. India Respiratory Drug Value Growth 2015-2020 ($ Millions)

Figure 58. Australia Respiratory Drug Consumption Growth 2015-2020 (M Units)

Figure 59. Australia Respiratory Drug Value Growth 2015-2020 ($ Millions)

Figure 60. Europe Respiratory Drug Consumption Market Share by Countries in 2019

Figure 61. Europe Respiratory Drug Value Market Share by Countries in 2019

Figure 62. Europe Respiratory Drug Consumption Market Share by Type in 2019

Figure 63. Europe Respiratory Drug Consumption Market Share by Application in 2019

Figure 64. Germany Respiratory Drug Consumption Growth 2015-2020 (M Units)

Figure 65. Germany Respiratory Drug Value Growth 2015-2020 ($ Millions)

Figure 66. France Respiratory Drug Consumption Growth 2015-2020 (M Units)

Figure 67. France Respiratory Drug Value Growth 2015-2020 ($ Millions)

Figure 68. UK Respiratory Drug Consumption Growth 2015-2020 (M Units)

Figure 69. UK Respiratory Drug Value Growth 2015-2020 ($ Millions)

Figure 70. Italy Respiratory Drug Consumption Growth 2015-2020 (M Units)

Figure 71. Italy Respiratory Drug Value Growth 2015-2020 ($ Millions)

Figure 72. Russia Respiratory Drug Consumption Growth 2015-2020 (M Units)

Figure 73. Russia Respiratory Drug Value Growth 2015-2020 ($ Millions)

Figure 74. Middle East & Africa Respiratory Drug Consumption Market Share by Countries in 2019

Figure 75. Middle East & Africa Respiratory Drug Value Market Share by Countries in 2019

Figure 76. Middle East & Africa Respiratory Drug Consumption Market Share by Type in 2019

Figure 77. Middle East & Africa Respiratory Drug Consumption Market Share by Application in 2019

Figure 78. Egypt Respiratory Drug Consumption Growth 2015-2020 (M Units)

Figure 79. Egypt Respiratory Drug Value Growth 2015-2020 ($ Millions)

Figure 80. South Africa Respiratory Drug Consumption Growth 2015-2020 (M Units)

Figure 81. South Africa Respiratory Drug Value Growth 2015-2020 ($ Millions)

Figure 82. Israel Respiratory Drug Consumption Growth 2015-2020 (M Units)

Figure 83. Israel Respiratory Drug Value Growth 2015-2020 ($ Millions)

Figure 84. Turkey Respiratory Drug Consumption Growth 2015-2020 (M Units)

Figure 85. Turkey Respiratory Drug Value Growth 2015-2020 ($ Millions)

Figure 86. GCC Countries Respiratory Drug Consumption Growth 2015-2020 (M Units)

Figure 87. GCC Countries Respiratory Drug Value Growth 2015-2020 ($ Millions)

Figure 88. Global Respiratory Drug Consumption Growth Rate Forecast (2021-2025) (M Units)

Figure 89. Global Respiratory Drug Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 90. Americas Respiratory Drug Consumption 2021-2025 (M Units)

Figure 91. Americas Respiratory Drug Value 2021-2025 ($ Millions)

Figure 92. APAC Respiratory Drug Consumption 2021-2025 (M Units)

Figure 93. APAC Respiratory Drug Value 2021-2025 ($ Millions)

Figure 94. Europe Respiratory Drug Consumption 2021-2025 (M Units)

Figure 95. Europe Respiratory Drug Value 2021-2025 ($ Millions)

Figure 96. Middle East & Africa Respiratory Drug Consumption 2021-2025 (M Units)

Figure 97. Middle East & Africa Respiratory Drug Value 2021-2025 ($ Millions)

Figure 98. United States Respiratory Drug Consumption 2021-2025 (M Units)

Figure 99. United States Respiratory Drug Value 2021-2025 ($ Millions)

Figure 100. Canada Respiratory Drug Consumption 2021-2025 (M Units)

Figure 101. Canada Respiratory Drug Value 2021-2025 ($ Millions)

Figure 102. Mexico Respiratory Drug Consumption 2021-2025 (M Units)

Figure 103. Mexico Respiratory Drug Value 2021-2025 ($ Millions)

Figure 104. Brazil Respiratory Drug Consumption 2021-2025 (M Units)

Figure 105. Brazil Respiratory Drug Value 2021-2025 ($ Millions)

Figure 106. China Respiratory Drug Consumption 2021-2025 (M Units)

Figure 107. China Respiratory Drug Value 2021-2025 ($ Millions)

Figure 108. Japan Respiratory Drug Consumption 2021-2025 (M Units)

Figure 109. Japan Respiratory Drug Value 2021-2025 ($ Millions)

Figure 110. Korea Respiratory Drug Consumption 2021-2025 (M Units)

Figure 111. Korea Respiratory Drug Value 2021-2025 ($ Millions)

Figure 112. Southeast Asia Respiratory Drug Consumption 2021-2025 (M Units)

Figure 113. Southeast Asia Respiratory Drug Value 2021-2025 ($ Millions)

Figure 114. India Respiratory Drug Consumption 2021-2025 (M Units)

Figure 115. India Respiratory Drug Value 2021-2025 ($ Millions)

Figure 116. Australia Respiratory Drug Consumption 2021-2025 (M Units)

Figure 117. Australia Respiratory Drug Value 2021-2025 ($ Millions)

Figure 118. Germany Respiratory Drug Consumption 2021-2025 (M Units)

Figure 119. Germany Respiratory Drug Value 2021-2025 ($ Millions)

Figure 120. France Respiratory Drug Consumption 2021-2025 (M Units)

Figure 121. France Respiratory Drug Value 2021-2025 ($ Millions)

Figure 122. UK Respiratory Drug Consumption 2021-2025 (M Units)

Figure 123. UK Respiratory Drug Value 2021-2025 ($ Millions)

Figure 124. Italy Respiratory Drug Consumption 2021-2025 (M Units)

Figure 125. Italy Respiratory Drug Value 2021-2025 ($ Millions)

Figure 126. Russia Respiratory Drug Consumption 2021-2025 (M Units)

Figure 127. Russia Respiratory Drug Value 2021-2025 ($ Millions)

Figure 128. Spain Respiratory Drug Consumption 2021-2025 (M Units)

Figure 129. Spain Respiratory Drug Value 2021-2025 ($ Millions)

Figure 130. Egypt Respiratory Drug Consumption 2021-2025 (M Units)

Figure 131. Egypt Respiratory Drug Value 2021-2025 ($ Millions)

Figure 132. South Africa Respiratory Drug Consumption 2021-2025 (M Units)

Figure 133. South Africa Respiratory Drug Value 2021-2025 ($ Millions)

Figure 134. Israel Respiratory Drug Consumption 2021-2025 (M Units)

Figure 135. Israel Respiratory Drug Value 2021-2025 ($ Millions)

Figure 136. Turkey Respiratory Drug Consumption 2021-2025 (M Units)

Figure 137. Turkey Respiratory Drug Value 2021-2025 ($ Millions)

Figure 138. GCC Countries Respiratory Drug Consumption 2021-2025 (M Units)

Figure 139. GCC Countries Respiratory Drug Value 2021-2025 ($ Millions)

Figure 140. GSK Respiratory Drug Market Share (2018-2020)

Figure 141. Sumitomo Dainippon Respiratory Drug Market Share (2018-2020)

Figure 142. AstraZeneca Respiratory Drug Market Share (2018-2020)

Figure 143. Vertex Respiratory Drug Market Share (2018-2020)

Figure 144. Roche Respiratory Drug Market Share (2018-2020)

Figure 145. Boehringer Ingelheim Respiratory Drug Market Share (2018-2020)

Figure 146. Chiesi Respiratory Drug Market Share (2018-2020)

Figure 147. Novartis Respiratory Drug Market Share (2018-2020)

Figure 148. Mylan Respiratory Drug Market Share (2018-2020)

Figure 149. Teva Respiratory Drug Market Share (2018-2020)

Figure 150. Merck Respiratory Drug Market Share (2018-2020)

Figure 151. Beximco Respiratory Drug Market Share (2018-2020)